Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00632021 · ClinicalTrials.gov registry record · NA
Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)
A NA study of Heart Failure and Acute Coronary Syndrome, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 862
- Enrollment target
- 2
- Study locations
NCT00632021 is a NA study of Heart Failure and Acute Coronary Syndrome that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 862 participants, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT00632021, a NA study of Heart Failure and Acute Coronary Syndrome, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 862 participants
- Enrollment target
- 2
- Study locations
Study Summary
Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focused program that provides educational assistance from pharmacists at the time of hospital discharge to people hospitalized with heart problems.
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist Intervention for Low-Literacy in Cardiovascular Disease
Study Locations (2)
Massachusetts
- Brigham and Women's Hospital - Boston
Tennessee
- Vanderbilt University Medical Center - Nashville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 862 participants |
| Start Date | 2008-05 |
| Est. Completion | 2012-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00632021
The ClinicalTrials.gov registry entry for NCT00632021 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 862 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,047-participant average among 397 other Heart Failure trials with a reported enrollment target (58% lower). The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 1 intervention - of which Pharmacist Intervention for Low-Literacy in Cardiovascular Disease is the first listed.
NCT00632021 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Massachusetts, Tennessee.
Frequently Asked Questions
What is clinical trial NCT00632021 about?
NCT00632021 is a clinical study titled "Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)". Many people who have recently left the hospital have difficulties managing their medications, and medication errors are common. Patients with low health literacy levels may have a particularly difficult time understanding medication dosing and instructions. This study will evaluate a literacy-focuse...
What is the current status of trial NCT00632021?
This trial is currently completed. It is a NA study. The enrollment target is 862 participants. The study started on 2008-05. Estimated completion is 2012-03.
What conditions does trial NCT00632021 study?
This clinical trial studies the following conditions: Heart Failure, Acute Coronary Syndrome.
What interventions are being tested in trial NCT00632021?
The interventions under investigation include: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease (BEHAVIORAL).
Who is sponsoring clinical trial NCT00632021?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00632021 being conducted?
This trial has 2 study locations across Massachusetts, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
Optimizing Heart Failure Therapies Among Patients With Limited Access in Denver
RECRUITING · NA
-
Hemodynamic Monitoring to Prevent Adverse Events foLlowing cardiOgenic Shock Trial
RECRUITING · NA
-
Effect of a Quality Improvement Initiative to Address Social Determinants of Health on Rehospitalization Rates in Patients With Heart Failure
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.